Data from longest reported follow-up for a Phase 3 trial with immunotherapy in metastatic non-small cell lung cancer demonstrate consistent,…
The Minerals Income Investment Fund of Ghana to acquire 6% interest in Ewoyaa for $27.9 million The sovereign wealth fund’s…
− Topline Results for TAK-279 Show that a Significantly Greater Proportion of Psoriatic Arthritis Patients Achieved at Least an ACR20…
DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) announced today that management will hold one-on-one…
Netcracker GenAI Telco Solution Accelerates the Adoption of High-Value Use Cases Across the Telecom Business WALTHAM, Mass.--(BUSINESS WIRE)--Netcracker Technology announced…
TOKYO--(BUSINESS WIRE)--#HS001--Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure, today announced that the case reports…
Clinical trials will advance treatment of COVID-19 infection. BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading…
HONG KONG SAR - Media OutReach - 11 September 2023 - Known for its variety of shopping and dining outlets,…
MELBOURNE, Australia & BOCA RATON, Fla. & DENVER--(BUSINESS WIRE)--AustralianSuper, Australia’s largest pension fund, today announced that it is investing €1.5…
Daiichi Sankyo and AstraZeneca’s ENHERTU showed objective response rates of 49% and 56% with 5.4 mg/kg and 6.4 mg/kg doses,…